MktsMarkets

Sarepta Therapeutics, Inc.
NASDAQ: SRPTKey statistics
SRPT News
Stories mentioning SRPT from around the web — every one is an open thread, so give it a like or add your take.
Loading news…
Financial statements
As filed, straight from the 10-Q — up to 19 years of history, free, with every line item chartable.
| Line item | Q1 '26Mar 31 | Q4 '25Dec 31 | Q3 '25Sep 30 | Q2 '25Jun 30 | Q1 '25Mar 31 | Q4 '24Dec 31 | Q3 '24Sep 30 | Q2 '24Jun 30 |
|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||
| Revenue | 330,515 | 442,934 | 370,043 | 513,123 | 611,523 | 658,412 | 429,771 | 360,548 |
| Cost of Goods Sold | ||||||||
| Gross Profit | (29,101) | 219,268 | 360,565 | 473,959 | 505,853 | 338,080 | 316,003 | |
| Operating Expenses | ||||||||
| Research & Development | ||||||||
| Sales General & Admin | 108,951 | 128,297 | 91,893 | 137,897 | 133,629 | 163,873 | 128,200 | 138,796 |
| Total Operating Expenses | ||||||||
| Operating Income (Loss) | 358,433 | (411,583) | (103,389) | 115,577 | (300,386) | 161,681 | 22,196 | (701.00) |
| Interest Income | 6,360 | 8,070 | 7,249 | 5,254 | 10,190 | 7,882 | 7,584 | 8,076 |
| Interest Expense | (21,713) | (40,765) | 1,900 | 5,228 | (4,503) | (23,975) | 4,918 | 4,832 |
| Other Expense | (15,259) | (22,188) | 47,953 | 38,061 | (83,132) | 10,062 | 11,810 | 14,278 |
| Pretax Income | 343,174 | (278,296) | (194,049) | 153,638 | (383,518) | 171,743 | 34,006 | 13,577 |
| Tax Provision | 12,215 | 4,551 | (14,102) | (43,254) | 63,990 | 12,694 | 395.00 | 7,117 |
| Net Income (Loss) | 330,959 | (412,226) | (50,568) | 196,892 | (447,508) | 159,049 | 33,611 | 6,460 |
| Earnings Per Share (Basic) | 3.15 | (3.93) | (0.50) | 2.01 | (4.60) | 1.65 | 0.35 | 0.07 |
| Earnings Per Share (Diluted) | 2.88 | (3.93) | (0.50) | 1.89 | (4.60) | 1.50 | 0.34 | 0.07 |
| Weighted Average Shares Outstanding (Basic) | 104,988 | 100,120 | 100,237 | 98,005 | 97,362 | 95,075 | 95,390 | 94,618 |
| Weighted Average Shares Outstanding (Diluted) | 121,916 | 100,120 | 100,237 | 106,623 | 97,362 | 107,875 | 100,448 | 99,144 |
Scroll the table sideways for older periods — the line-item column and the period header stay put. Hover a row and use the chart handle to plot it over the full history.
About SRPT
Sarepta Therapeutics, Inc. (NASDAQ: SRPT) is a stock listed on the Nasdaq Stock Market under the ticker symbol SRPT. It last traded at $16.42 (Nov 10, 2026, 4:00 PM ET), down 4.8% on the day. That gives Sarepta Therapeutics a market capitalisation of $1.8B and a price-to-earnings ratio of 125.3.
Over the past 52 weeks SRPT has traded between $14.68 and $24.68.
Revenue for the quarter ended Mar 31, 2026 was $330.5M; net income $331.0M. Revenue was down 46.0% from $611.5M in the quarter ended Mar 31, 2025.
| Quarter ended | Revenue | Net income | Margin |
|---|---|---|---|
| Mar 31, 2026 | $330.5M | $331.0M | 100.1% |
| Dec 31, 2025 | $442.9M | -$412.2M | -93.1% |
| Sep 30, 2025 | $370.0M | -$50.6M | -13.7% |
| Jun 30, 2025 | $513.1M | $196.9M | 38.4% |
From Sarepta Therapeutics’s quarterly (10-Q) filings, in US dollars.
Take a break — play a market game
Seven free games built around the markets. No download, no sign-up: they run right here in your browser.
Latest News
Market news from around the web — every story is an open thread, so give it a like or add your take.
Loading news…